Sivik Global Healthcare’s Danaher DHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.79M | Hold |
20,000
| – | – | 2.88% | 14 |
|
|
2026
Q1 | $3.79M | Sell |
20,000
-3,000
| -13% | -$639K | 2.88% | 14 |
|
|
2025
Q4 | $5.26M | Sell |
23,000
-12,000
| -34% | -$2.64M | 1.53% | 22 |
|
|
2025
Q3 | $6.94M | Sell |
35,000
-5,000
| -13% | -$995K | 2.02% | 14 |
|
|
2025
Q2 | $7.9M | Buy |
40,000
+5,000
| +14% | +$970K | 2.15% | 16 |
|
|
2025
Q1 | $7.17M | Buy |
35,000
+10,000
| +40% | +$2.18M | 3.88% | 7 |
|
|
2024
Q4 | $5.74M | Sell |
25,000
-5,000
| -17% | -$1.23M | 3.02% | 13 |
|
|
2024
Q3 | $8.34M | Hold |
30,000
| – | – | 3.53% | 10 |
|
|
2024
Q2 | $7.5M | Hold |
30,000
| – | – | 2.69% | 12 |
|
|
2024
Q1 | $7.49M | Buy |
30,000
+5,000
| +20% | +$1.22M | 1.76% | 11 |
|
|
2023
Q4 | $5.78M | Sell |
25,000
-6,020
| -19% | -$1.28M | 2.42% | 21 |
|
|
2023
Q3 | $6.82M | Buy |
31,020
+2,820
| +10% | +$629K | 3.45% | 13 |
|
|
2023
Q2 | $6M | Buy |
28,200
+5,640
| +25% | +$1.19M | 1.4% | 24 |
|
|
2023
Q1 | $5.04M | Hold |
22,560
| – | – | 2.17% | 24 |
|
|
2022
Q4 | $5.31M | Sell |
22,560
-5,640
| -20% | -$1.31M | 2.5% | 20 |
|
|
2022
Q3 | $6.46M | Sell |
28,200
-1,128
| -4% | -$276K | 3.59% | 6 |
|
|
2022
Q2 | $6.59M | Sell |
29,328
-1,692
| -5% | -$390K | 3.75% | 9 |
|
|
2022
Q1 | $8.07M | Buy |
31,020
+2,820
| +10% | +$706K | 3.33% | 4 |
|
|
2021
Q4 | $8.22M | Sell |
28,200
-5,640
| -17% | -$1.55M | 3.52% | 5 |
|
|
2021
Q3 | $9.13M | Hold |
33,840
| – | – | 2.18% | 12 |
|
|
2021
Q2 | $8.05M | Sell |
33,840
-8,460
| -20% | -$1.88M | 1.57% | 17 |
|
|
2021
Q1 | $8.44M | Sell |
42,300
-2,820
| -6% | -$573K | 3.08% | 9 |
|
|
2020
Q4 | $8.89M | Sell |
45,120
-5,640
| -11% | -$1.13M | 3.62% | 8 |
|
|
2020
Q3 | $9.69M | Sell |
50,760
-39,480
| -44% | -$7.02M | 4.17% | 2 |
|
|
2020
Q2 | $8.06M | Sell |
90,240
-39,480
| -30% | -$5.67M | 2.67% | 16 |
|
|
2020
Q1 | $10.2M | Buy |
129,720
+73,320
| +130% | +$9.88M | 4.02% | 6 |
|
|
2019
Q4 | $7.67M | Buy |
56,400
+5,640
| +11% | +$713K | 2.85% | 11 |
|
|
2019
Q3 | $6.5M | Sell |
50,760
-5,640
| -10% | -$706K | 3.28% | 9 |
|
|
2019
Q2 | $7.15M | Sell |
56,400
-11,280
| -17% | -$1.34M | 1.73% | 6 |
|
|
2019
Q1 | $7.92M | Buy |
67,680
+16,920
| +33% | +$1.73M | 2.92% | 7 |
|
|
2018
Q4 | $4.64M | Buy |
+50,760
| New | +$4.61M | 2.5% | 18 |
|
|
2017
Q4 | – | Sell |
-62,040
| Closed | -$4.72M | – | 73 |
|
|
2017
Q3 | $4.72M | Buy |
+62,040
| New | +$4.59M | 1.61% | 25 |
|
Other funds holding DHR
MBI
DC
JIC
ATO
CF
DLA
BPCE
Sivik Global Healthcare's DHR Position: Q2 2026 in Review
Sivik Global Healthcare held its Danaher (DHR) position steady in Q2 2026 at 20,000 shares worth $3.79M. The position accounts for 2.88% of the portfolio, ranked #14.
Sivik Global Healthcare first reported a position in DHR in Q3 2017 and has held it in 32 quarters since. The position peaked at $10.2M in Q1 2020. 607 funds tracked by Wall St. Rank hold DHR as of Q2 2026.
- Sivik Global Healthcare held 20,000 shares of Danaher worth $3.79M as of Q2 2026.
- Sivik Global Healthcare left its Danaher share count unchanged in Q2 2026.
- Danaher made up 2.88% of Sivik Global Healthcare's portfolio in Q2 2026, its #14 holding.
- Sivik Global Healthcare first reported a position in Danaher in Q3 2017 and has held it in 32 quarters since.
- Sivik Global Healthcare's Danaher position peaked at $10.2M in Q1 2020.
- 607 funds tracked by Wall St. Rank held Danaher as of Q2 2026.
Based on Sivik Global Healthcare's 13F filing for Q2 2026, filed 20 Jul 2026.